Dina Tzemach

1.8k total citations
19 papers, 1.5k citations indexed

About

Dina Tzemach is a scholar working on Oncology, Biomaterials and Molecular Biology. According to data from OpenAlex, Dina Tzemach has authored 19 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Oncology, 11 papers in Biomaterials and 8 papers in Molecular Biology. Recurrent topics in Dina Tzemach's work include Nanoparticle-Based Drug Delivery (11 papers), RNA Interference and Gene Delivery (7 papers) and Radiopharmaceutical Chemistry and Applications (4 papers). Dina Tzemach is often cited by papers focused on Nanoparticle-Based Drug Delivery (11 papers), RNA Interference and Gene Delivery (7 papers) and Radiopharmaceutical Chemistry and Applications (4 papers). Dina Tzemach collaborates with scholars based in Israel and United States. Dina Tzemach's co-authors include Alberto Gabizón, Hilary Shmeeda, Dorit Goren, Aviva T. Horowitz, Samuel Zalipsky, Lidia Mak, Yasmine Amitay, Jenny Gorin, Alberto Gabizon and Rama Sapir and has published in prestigious journals such as Journal of Clinical Oncology, PLoS ONE and Journal of Controlled Release.

In The Last Decade

Dina Tzemach

19 papers receiving 1.5k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Dina Tzemach Israel 15 982 759 515 300 164 19 1.5k
Dinah Tzemach Israel 9 794 0.8× 587 0.8× 405 0.8× 377 1.3× 121 0.7× 11 1.4k
Derek W. Bartlett United States 17 706 0.7× 1.9k 2.5× 488 0.9× 262 0.9× 168 1.0× 28 2.7k
Robert Pola Czechia 19 691 0.7× 529 0.7× 647 1.3× 109 0.4× 193 1.2× 58 1.4k
Dorit Goren Israel 18 1.5k 1.6× 1.3k 1.7× 661 1.3× 475 1.6× 267 1.6× 19 2.4k
James Z. Hui United States 11 610 0.6× 550 0.7× 700 1.4× 128 0.4× 212 1.3× 15 1.4k
Bela Kaufman Israel 6 644 0.7× 546 0.7× 349 0.7× 280 0.9× 95 0.6× 7 1.3k
Aviva T. Horowitz Israel 20 1.5k 1.5× 1.3k 1.8× 719 1.4× 514 1.7× 270 1.6× 29 2.6k
Gopal Anyarambhatla United States 6 1.0k 1.1× 671 0.9× 925 1.8× 118 0.4× 156 1.0× 6 1.6k
Martin Hossann Germany 19 887 0.9× 568 0.7× 769 1.5× 82 0.3× 91 0.6× 28 1.4k
Susan K. Hobbs United States 12 1.1k 1.1× 799 1.1× 1.1k 2.1× 202 0.7× 402 2.5× 36 2.5k

Countries citing papers authored by Dina Tzemach

Since Specialization
Citations

This map shows the geographic impact of Dina Tzemach's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dina Tzemach with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dina Tzemach more than expected).

Fields of papers citing papers by Dina Tzemach

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Dina Tzemach. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dina Tzemach. The network helps show where Dina Tzemach may publish in the future.

Co-authorship network of co-authors of Dina Tzemach

This figure shows the co-authorship network connecting the top 25 collaborators of Dina Tzemach. A scholar is included among the top collaborators of Dina Tzemach based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Dina Tzemach. Dina Tzemach is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
Gabizón, Alberto, Patricia Ohana, Yasmine Amitay, et al.. (2021). Liposome co-encapsulation of anti-cancer agents for pharmacological optimization of nanomedicine-based combination chemotherapy. Cancer Drug Resistance. 4(2). 463–484. 11 indexed citations
2.
Shmeeda, Hilary, Yasmine Amitay, Jenny Gorin, et al.. (2016). Coencapsulation of alendronate and doxorubicin in pegylated liposomes: a novel formulation for chemoimmunotherapy of cancer. Journal of drug targeting. 24(9). 878–889. 38 indexed citations
3.
Amitay, Yasmine, Hilary Shmeeda, Yogita P. Patil, et al.. (2015). Pharmacologic Studies of a Prodrug of Mitomycin C in Pegylated Liposomes (Promitil®): High Stability in Plasma and Rapid Thiolytic Prodrug Activation in Tissues. Pharmaceutical Research. 33(3). 686–700. 33 indexed citations
4.
Shmeeda, Hilary, Yasmine Amitay, Dina Tzemach, Jenny Gorin, & Alberto Gabizón. (2013). Liposome encapsulation of zoledronic acid results in major changes in tissue distribution and increase in toxicity. Journal of Controlled Release. 167(3). 265–275. 64 indexed citations
5.
6.
Gabizón, Alberto, Yasmine Amitay, Dina Tzemach, et al.. (2011). Therapeutic efficacy of a lipid-based prodrug of mitomycin C in pegylated liposomes: Studies with human gastro-entero-pancreatic ectopic tumor models. Journal of Controlled Release. 160(2). 245–253. 52 indexed citations
7.
Shmeeda, Hilary, Yasmine Amitay, Jenny Gorin, et al.. (2010). Delivery of zoledronic acid encapsulated in folate-targeted liposome results in potent in vitro cytotoxic activity on tumor cells. Journal of Controlled Release. 146(1). 76–83. 77 indexed citations
8.
Gabizón, Alberto, Dina Tzemach, Jenny Gorin, et al.. (2009). Improved therapeutic activity of folate-targeted liposomal doxorubicin in folate receptor-expressing tumor models. Cancer Chemotherapy and Pharmacology. 66(1). 43–52. 99 indexed citations
9.
Shmeeda, Hilary, Dina Tzemach, Lidia Mak, & Alberto Gabizón. (2009). Her2-targeted pegylated liposomal doxorubicin: Retention of target-specific binding and cytotoxicity after in vivo passage. Journal of Controlled Release. 136(2). 155–160. 80 indexed citations
10.
La‐Beck, Ninh M., Beth A. Zamboni, Dina Tzemach, et al.. (2009). Evaluation of the relationship between patient factors and the reduction in clearance of pegylated liposomal doxorubicin. Journal of Clinical Oncology. 27(15_suppl). 2548–2548. 3 indexed citations
11.
Shmeeda, Hilary, Jenny Gorin, Lidia Mak, et al.. (2007). Intracellular delivery of liposome-encapsulated zoledronic acid via folate receptor results in significant inhibition of tumor cell growth. Molecular Cancer Therapeutics. 6. 1 indexed citations
12.
Gabizón, Alberto, Rut Isacson, Ora Rosengarten, et al.. (2007). An open-label study to evaluate dose and cycle dependence of the pharmacokinetics of pegylated liposomal doxorubicin. Cancer Chemotherapy and Pharmacology. 61(4). 695–702. 95 indexed citations
13.
Hagstrom, Thomas, et al.. (2007). LOCAL HIGH-ORDER ABSORBING BOUNDARY CONDITIONS FOR TIME-DEPENDENT WAVES IN GUIDES. Journal of Computational Acoustics. 15(1). 1–22. 39 indexed citations
14.
Gabizón, Alberto, Rut Isacson, Ora Rosengarten, et al.. (2006). An open-label study to evaluate dose and cycle dependence of the pharmacokinetics (PK) of pegylated liposomal doxorubicin (PLD). Journal of Clinical Oncology. 24(18_suppl). 2012–2012. 2 indexed citations
15.
Shmeeda, Hilary, et al.. (2006). Intracellular uptake and intracavitary targeting of folate-conjugated liposomes in a mouse lymphoma model with up-regulated folate receptors. Molecular Cancer Therapeutics. 5(4). 818–824. 109 indexed citations
16.
Gabizón, Alberto, Aviva T. Horowitz, Dorit Goren, et al.. (2003). In vivo fate of folate-targeted polyethylene-glycol liposomes in tumor-bearing mice.. PubMed. 9(17). 6551–9. 253 indexed citations
17.
Goren, Dorit, et al.. (2000). Nuclear delivery of doxorubicin via folate-targeted liposomes with bypass of multidrug-resistance efflux pump.. PubMed. 6(5). 1949–57. 332 indexed citations
18.
Goren, Dorit, et al.. (1999). Pharmacological studies of cisplatin encapsulated in long-circulating liposomes in mouse tumor models. Anti-Cancer Drugs. 10(10). 911–920. 120 indexed citations
19.
Cabanes, Anna, Dina Tzemach, Dorit Goren, Aviva T. Horowitz, & Alberto Gabizón. (1998). Comparative study of the antitumor activity of free doxorubicin and polyethylene glycol-coated liposomal doxorubicin in a mouse lymphoma model.. PubMed. 4(2). 499–505. 60 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Dinah Tzemach Breakdown of academic impact, for papers by Derek W. Bartlett Breakdown of academic impact, for papers by Robert Pola Breakdown of academic impact, for papers by Dorit Goren Breakdown of academic impact, for papers by James Z. Hui Breakdown of academic impact, for papers by Bela Kaufman Breakdown of academic impact, for papers by Aviva T. Horowitz Breakdown of academic impact, for papers by Gopal Anyarambhatla Breakdown of academic impact, for papers by Martin Hossann Breakdown of academic impact, for papers by Susan K. Hobbs
Rankless by CCL
2026